← All companies

JAZZ

Jazz Pharmaceuticals plc

JAZZ Nasdaq Pharmaceutical Preparations EDGAR ↗

$251.58

-1.28 -0.51%

Key statistics

from XBRL data in SEC filings

Market cap

$16.3B

Revenue (TTM)

$4.60B

Net income (TTM)

$941M

EPS (TTM)

$14.63

P/E ratio

17.2

Dividend yield

—

Free cash flow

$1.30B

Cash

$1.62B

Total assets

$11.1B

Gross margin

47.8%

52-week range

$105.00 – $261.30

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Shareholder vote results Jul 24, 2026 8-K Director or officer change May 29, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 24, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Director or officer change Oct 28, 2025 8-K Other events Oct 22, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results Jul 25, 2025 8-K Director or officer change; Regulation FD disclosure Jul 10, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 25, 2025 8-K Regulation FD disclosure; Other events Apr 21, 2025 8-K Entered a material agreement Apr 8, 2025 8-K/A Entered a material agreement; Regulation FD disclosure Mar 5, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Director or officer change Dec 16, 2024 8-K Entered a material agreement; Took on a direct financial obligation Nov 26, 2024 8-K Other events Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Terminated a material agreement Oct 16, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Sep 6, 2024 8-K Other events Aug 28, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Shareholder vote results Jul 26, 2024